JCRB0821 NUGC-2
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0821 | Cell Name | NUGC-2 |
---|---|---|---|
Profile | adenocarcinoma, poorly differentiated | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 56 |
Identity | available | Tissue for Primary Cancer | stomach |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | gastric cancer | |
Life Span | Crisis PDL | ||
Morphology | Character | gastric cancer | |
Classify | Established by | Akiyama,S. | |
Registered by | Akiyama,M. | Regulation for Distribution | |
Comment | Year | 1987 | |
Medium | RPMI1640 medium with 15% fetal calf serum | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week |
Cell Number on Passage | split ratio=1/1 | Race | |
CO2 Conc. | 5 % | Tissue Sampling | stomach |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | NT | ||||||
Notes |
Reference | |
---|---|
Pubmed id:2121682 | Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies. Koyama K,Akiyama K,Kawahara H,Egashira A,Murakami H Jpn J Cancer Res. 1990 Oct;81(10):967-70 |
Pubmed id:3172586 | Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Akiyama S,Amo H,Watanabe T,Matsuyama M,Sakamoto J,Imaizumi M,Ichihashi H,Kondo T,Takagi H Jpn J Surg. 1988 Jul;18(4):438-46 |
Images |
---|
LOT Information
Cell No. | JCRB0821 | Cell Name | |
---|---|---|---|
LOT No. | 07132009 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 15% fetal bovine serum (GIBCO cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 3 -5 x 10^4 cells/ml | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 2.5 days | Cell Number in Vial (cells/1ml) | 8.3 x 10^5 |
Viability at cell freezing (%) | 91.6 | Antibiotics Used | free |
Passage Number | P54 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0821 | Cell Name | NUGC-2 |
---|---|---|---|
LOT No. | 060888 | Lot Specification | distribution |
Medium | RPMI1640+10% FCS+2mM l-Gln+4mM HEPES+0.05%NaHCO3 | Temperature | 37 |
Cell Density at Seeding | split ratio=1:6 | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 5.8x10^5 |
Viability at cell freezing (%) | NT | Antibiotics Used | free |
Passage Number | *P4 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0821 | Cell Name | |
---|---|---|---|
LOT No. | 090495 | Lot Specification | distribution |
Medium | RPMI1640 + 10% FCS | Temperature | 37 |
Cell Density at Seeding | split ratio=1:6 | Methods for Passages | 0.25% trypsin and dilute in fresh medium. change medium twice a week |
Doubling Time | Cell Number in Vial (cells/1ml) | ca3-5x10^6 | |
Viability at cell freezing (%) | Antibiotics Used | penicillin/streptomycin | |
Passage Number | P44 (MC210) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | confirmed as human |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0821 | Cell Name | |
---|---|---|---|
LOT No. | 091195 | Lot Specification | distribution |
Medium | RPMI1640 + 10% FCS | Temperature | 37 |
Cell Density at Seeding | split ratio=1:6 | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week |
Doubling Time | Cell Number in Vial (cells/1ml) | ca3-5x10^6 | |
Viability at cell freezing (%) | Antibiotics Used | penicillin/streptomycin | |
Passage Number | P45 (MC210) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | confirmed as human |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0821 | Cell Name | |
---|---|---|---|
LOT No. | 091895 | Lot Specification | distribution |
Medium | RPMI1640 + 10% FCS | Temperature | 37 |
Cell Density at Seeding | split ratio=1:6 | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week |
Doubling Time | Cell Number in Vial (cells/1ml) | ca3-5x10^6 | |
Viability at cell freezing (%) | Antibiotics Used | penicillin/streptomycin | |
Passage Number | P43 (MC210) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | confirmed as human |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0821 | Cell Name | |
---|---|---|---|
LOT No. | 120297 | Lot Specification | distribution |
Medium | RPMI1640 medium with 15% fetal calf serum (FCS lot; BioWhittaker 6M0121) | Temperature | 37 C |
Cell Density at Seeding | 1-2 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin |
Doubling Time | Cell Number in Vial (cells/1ml) | 3.9 x 10^5 | |
Viability at cell freezing (%) | 97.0 | Antibiotics Used | free |
Passage Number | P48 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0821 | Cell Name | NUGC-2 |
---|---|---|---|
LOT No. | 04282014 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 15% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
Cell Density at Seeding | 1 - 2 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | Cell Number in Vial (cells/1ml) | 7.0 x 10^5 | |
Viability at cell freezing (%) | 87.5 | Antibiotics Used | free |
Passage Number | P53 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:10,12 D13S317:8,11 D7S820:11 D16S539:7,12 VWA:17,18 TH01:7 AM:X TPOX:11 CSF1PO:10,12 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 87.5 | Additional information |